Page last updated: 2024-11-07

spironolactone and Female Genital Neoplasms

spironolactone has been researched along with Female Genital Neoplasms in 2 studies

Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biggar, RJ1
Andersen, EW1
Wohlfahrt, J1
Melbye, M1
Eschner, J1
Fodor, L1
Winter, C1
Ahnefeld, FW1

Other Studies

2 other studies available for spironolactone and Female Genital Neoplasms

ArticleYear
Spironolactone use and the risk of breast and gynecologic cancers.
    Cancer epidemiology, 2013, Volume: 37, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Cohort Studies; Denmark; Drug Prescriptions; Femal

2013
[Pre- and intraoperative use of potassium canrenoate in addominal surgery].
    Die Medizinische Welt, 1973, May-11, Volume: 24, Issue:19

    Topics: Adult; Female; Genital Neoplasms, Female; Humans; Laparotomy; Middle Aged; Premedication; Spironolac

1973